Summit Securities Group’s MaxLinear MXL Stock Holding History

Summit Securities Group’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-918	Closed	-$16K	–	1299
2026 Q1	$16K	Buy	+918	New	+$16.5K	﹤0.01%	565
2015 Q3	–	Sell	-1,800	Closed	-$22K	–	460
2015 Q2	$22K	Buy	+1,800	New	+$18.1K	0.01%	306

Other funds holding MXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Summit Securities Group's MXL Position: Q2 2026 in Review

Summit Securities Group sold out of MaxLinear (MXL) in Q2 2026, closing a stake of 918 shares — an estimated $16K sold.

Summit Securities Group first reported a position in MXL in Q2 2015 and held it in 2 quarters. The position peaked at $22K in Q2 2015. 433 funds tracked by Wall St. Rank hold MXL as of Q2 2026.

Summit Securities Group reported no remaining MaxLinear position as of Q2 2026 after selling out during the quarter.
Summit Securities Group sold 918 MaxLinear shares in Q2 2026, an estimated $16K.
Summit Securities Group first reported a position in MaxLinear in Q2 2015 and held it in 2 quarters.
Summit Securities Group's MaxLinear position peaked at $22K in Q2 2015.
433 funds tracked by Wall St. Rank held MaxLinear as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.